Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

FDA grants breakthrough status to Norroy kidney cancer imaging agent

Biotechnology firm Norroy Bioscience secured Breakthrough Therapy and Fast Track designations from the US FDA on 19 August 2026 for its kidney cancer imaging product

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Health & Medicine

More from Thursday 20 August →